Results 131 to 140 of about 1,464,129 (347)

Metabolomics in cancer research and emerging applications in clinical oncology [PDF]

, 2021
Daniel R. Schmidt, Rutulkumar Patel, David G. Kirsch, Caroline A. Lewis, Matthew G. Vander Heiden, Jason W. Locasale   +5 more
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

The impact of local symptoms on health‐related quality of life in vulvar cancer survivors—A nationwide prospective study

Acta Obstetricia et Gynecologica Scandinavica
Introduction Vulvar cancer may cause serious local symptoms that may impact negatively on the woman's health‐related quality of life (HRQOL). However, knowledge about the prevalence of vulvar and lymphedema symptoms at diagnosis and during follow‐up is ...
Diana Zach, Pernille T. Jensen, Henrik Falconer, Zuzana Kolkova, Katja Stenström Bohlin, Preben Kjølhede, Ivette Raices Cruz, Elisabeth Åvall‐Lundqvist, Angelique Flöter Rådestad   +8 more
doaj   +1 more source

American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care [PDF]

, 2012
Thomas J. Smith, Sarah Temin, Erin R. Alesi, Amy P. Abernethy, Tracy A. Balboni, Ethan Basch, Betty Ferrell, M. Loscalzo, Diane E. Meier, Judith A. Paice, Jeffrey Peppercorn, Mark R. Somerfield, Ellen Stovall, Jamie H. Von Roenn   +13 more
openalex   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up. [PDF]

, 2019
PurposeIn the initial PALOMA-2 (NCT01740427) analysis with median follow-up of 23 months, palbociclib plus letrozole significantly prolonged progression-free survival (PFS) in women with estrogen receptor-positive (ER+)/human epidermal growth factor ...
Bartlett, C Huang, Castrellon, A, Diéras, V, Ettl, J, Finn, RS, Gauthier, ER, Gelmon, KA, Harbeck, N, Iyer, S, Joy, AA, Lipatov, O, Lu, DR, Mori, A, Rugo, HS, Slamon, DJ   +14 more
core  

Correlation of Ga-68 PSMA PET/CT Positivity with Gleason Scores and Serum PSA Levels in Initial Staging of Prostate Adenocarcinoma, and the Contribution of PET/CT Imaging to Patient Management

Acta Haematologica Oncologica Turcica
Aim: Prostate cancer is the second most frequently diagnosed malignancy and the fifth leading cause of cancer-related mortality worldwide. Accurate staging at diagnosis is crucial for guiding treatment decisions.
İpek Öztürk, Gülin Uçmak, Bedriye Büşra Demirel, Semra Demirtaş Şenlik, Hülya Efetürk, Aykut Kürşat Fidan, Halil Başar   +6 more
doaj   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Focal Spot, Spring 1978 [PDF]

, 1978
https://digitalcommons.wustl.edu/focal_spot_archives/1020/thumbnail ...

core   +1 more source

Statistics and Clinical Oncology

Clinical Oncology, 1996
J, Brown, D, Machin
openaire   +3 more sources